Management of virus cental nervous system disease.
D002908:Chronic Disease; D003128:Coma / Q000628:therapy; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage; D004679:Encephalomyelitis / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D005334:Fever / Q000628:therapy; D006261:Headache / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects / Q000627:therapeutic use; D007970:Leukopenia / Q000139:chemically induced; D008587:Meningitis, Viral / Q000188:drug therapy / Q000628:therapy; D001523:Mental Disorders / Q000188:drug therapy / Q000209:etiology; D010146:Pain / Q000188:drug therapy; D010243:Paralysis / Q000628:therapy; D012131:Respiratory Insufficiency / Q000628:therapy; D012293:Rifampin / Q000627:therapeutic use; D014839:Vomiting / Q000188:drug therapy
D003609:Dactinomycin; D003907:Dexamethasone; D007065:Idoxuridine; D012293:Rifampin; D003630:Daunorubicin